[1]
Marchesi, F., Ensoli, F., Terrenato, I., Papa, E., Pimpinelli, F., Prignano, G., Spadea, A., Cavallo, I., Di Domenico, E.G., Toma, L. and Mengarelli, A. 2020. Ceftolozane-Tazobatam for febrile neutropenia treatment in hematologic malignancy patients colonized by multi-resistant Enterobacteriaceae: preliminary results from a prospective cohort study: Ceftolozane-Tazobatam for febrile neutropenia. Mediterranean Journal of Hematology and Infectious Diseases. 12, 1 (Sep. 2020), e2020065. DOI:https://doi.org/10.4084/mjhid.2020.065.